Results 61 to 70 of about 32,318 (184)

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 329-347, February 2026.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, Stefanie Lip, Hannah O'Neill, Kerry Burke, Vicky Chaplin, Alexander S. F. Doney, Salim Elyas, Nicholas Greaves, Sophie Harding, David Hargroves, Judith Hayward, Dyfrig A. Hughes, Tom A. T. Hughes, Sree Kondapally, Patrick Mok, Aaron Peace, Imran Rafi, Simon Ray, Vicky Stinton, Luigi Venetucci, Munir Pirmohamed   +22 more
wiley   +1 more source

Heat Therapy: Targeting Health, Disease, and Disability

Comprehensive Physiology, Volume 16, Issue 1, February 2026.
The predominance of evidence suggests heat therapy has an impact on all aspects of health and performance, but the drivers of that improvement, the extent to which they are improved, and the specific populations in which improvements manifest are far from completely understood.
Rauchelle E. Richey, Robert D. Hyldahl, Brendan W. Kaiser, Paige C. Geiger, John R. Halliwill, Christopher T. Minson   +5 more
wiley   +1 more source

Abstract No. 142 Percutaneous interspinous spacer placement for neurogenic intermittent claudication in cancer patients with lumbar spinal stenosis [PDF]

, 2021
Jeremiah Stringam, J. Kuban, S. Chen, Steven Yevich, Claudio E. Tatsui, Rahul A. Sheth   +5 more
openalex   +1 more source

Outcomes of an Intravenous to Subcutaneous Infliximab (CT‐P13) Strategy in Takayasu Arteritis: A Proof‐of‐Concept Prospective Study

ACR Open Rheumatology, Volume 8, Issue 1, January 2026.
Objectives To evaluate persistence, outcomes, safety, and remission maintenance after switching from intravenous infliximab (IV‐IFX) to subcutaneous infliximab (SC‐IFX, CT‐P13) in patients with Takayasu arteritis (TA). Methods We conducted a prospective, single‐center, proof‐of‐concept observational study of consecutive adults with TA in sustained ...
Luca Iorio, Federica Davanzo, Eleonora Fiorin, Marta Codirenzi, Roberta Prevedello, Andrea Doria, Roberto Padoan   +6 more
wiley   +1 more source

Latent Health Status Trajectories in Individuals With New or Worsening Claudication Symptoms

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background While peripheral artery disease care for claudication aims to improve health status (symptoms, physical function, and quality of life), health status trajectories remain unclear.
Scott Grubman, Gaëlle Romain, Jacob Cleman, Lindsey Scierka, Carmen Pajarillo, Jonathan Kluger, Carlos Mena‐Hurtado, Kim G. Smolderen   +7 more
doaj   +1 more source

Differences Between Patients With Intermittent Claudication and Critical Limb Ischemia Undergoing Endovascular Intervention: Insights From the Excellence in Peripheral Artery Disease Registry [PDF]

, 2021
Kunal Patel, Yulun Liu, Farshid Etaee, Chirag Patel, Peter Monteleone, Mitul Patel, Mohamad Amer Alaiti, Christopher Metzger, Avantika Banerjee, Nicole Minniefield, Ishita Tejani, Emmanouil S. Brilakis, Mehdi H. Shishehbor, Subhash Banerjee   +13 more
openalex   +1 more source

Exercise prescription using the heart of claudication pain onset in patients with intermittent claudication

Clinics, 2013
OBJECTIVE: To assess the acute metabolic and cardiovascular responses to walking exercise at an intensity corresponding to the heart rate of claudication pain onset and to investigate the effects of a 12-week walking training program at this intensity on
Gabriel Grizzo Cucato, Marcel da Rocha Chehuen, Luis Augusto Riani Costa, Raphael Mendes Ritti-Dias, Nelson Wolosker, John Michael Saxton, Cláudia Lúcia de Moraes Forjaz   +6 more
doaj   +1 more source

Spinal Cord Stimulation as a Potential Therapeutic Modality for Managing Concurrent Chronic Low Back and Abdominal Pain Complicated by Device Migration: A Case Report

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT A 48‐year‐old man with chronic pancreatitis–related chronic abdominal pain (CAP) and concurrent chronic low back pain (LBP) with radiculopathy had inadequate relief from injectable and opioid therapies. A spinal cord stimulation (SCS) trial with dual leads spanning T4–T6 produced significant CAP relief, leading to permanent implantation at T5,
Bi Mo, Sandra Sacks, Jerry Markar
wiley   +1 more source

Hipertensión arterial secundaria a coartación de la aorta: A propósito de 1 caso Blood hypertension secondary to aorta coarctation: A propos of a case

Revista Cubana de Medicina, 2007
Se presentó 1 caso con forma de hipertensión arterial refractaria secundaria a coartación de la aorta diagnósticada a los 41 años de edad. Se trató de un paciente masculino con historia de hipertensión arterial desde los 19 años que no lograba control de
Manuel Antonio Fernández Arias, Alfredo Vázquez Vigoa, Yamilé Roselló Azcanio, Germinal Álvarez Batard, Liodelvio Martínez Fernández, Annerys Méndez Rosabal   +5 more
doaj  

Cross-cultural adaptation of the Zurich Claudication Questionnaire. Validation study of the Spanish version

Anales del Sistema Sanitario de Navarra, 2015
Background. In the last few years, instruments that measure outcomes and quality of life as perceived by the patient have become tools of great clinical value.
A. M. Hidalgo Ovejero, M. Menéndez García, B. Bermejo Fraile, S. García Mata, T. Forcén Alonso, P. Mateo Sebastián   +5 more
doaj   +1 more source